Jack W.  Lasersohn net worth and biography

Jack Lasersohn Biography and Net Worth

Director of Silk Road Medical
Jack W. Lasersohn J.D. serves as Independent Director of the Company. Mr. Lasersohn has been a general partner, or a principal of the general partner, of The Vertical Group, L.P., a private venture capital firm that is focused on the fields of medical technology and biotechnology. The Vertical Group was a co-founder of our company. Prior to joining The Vertical Group’s predecessor, F. Eberstadt, in 1981, Mr. Lasersohn was a corporate attorney with Cravath, Swaine & Moore LLP. Mr. Lasersohn served on the board of directors of Masimo Corporation, a publicly traded global medical technology company, from January 1995 to 2017 and has served on the board of directors of OncoMed Pharmaceuticals, Inc., a publicly traded clinical development-stage biopharmaceutical company, since July 2005. He also serves on the boards of a number of private medical device and biotechnology companies. Mr. Lasersohn is the past Chairman of the Medical Industry Group of the National Venture Capital Association, or NVCA, and previously served on the Executive Committee of the board of directors of the NVCA. Mr. Lasersohn has also served, by appointment, on various committees advising the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services.

What is Jack W. Lasersohn's net worth?

The estimated net worth of Jack W. Lasersohn is at least $131,099.81 as of June 3rd, 2021. Lasersohn owns 4,769 shares of Silk Road Medical stock worth more than $131,100 as of December 21st. This net worth evaluation does not reflect any other investments that Lasersohn may own. Learn More about Jack W. Lasersohn's net worth.

How do I contact Jack W. Lasersohn?

The corporate mailing address for Lasersohn and other Silk Road Medical executives is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. Silk Road Medical can also be reached via phone at (408) 720-9002 and via email at [email protected]. Learn More on Jack W. Lasersohn's contact information.

Has Jack W. Lasersohn been buying or selling shares of Silk Road Medical?

Jack W. Lasersohn has not been actively trading shares of Silk Road Medical within the last three months. Most recently, Jack W. Lasersohn sold 5,427 shares of the business's stock in a transaction on Thursday, June 3rd. The shares were sold at an average price of $45.60, for a transaction totalling $247,471.20. Following the completion of the sale, the director now directly owns 4,769 shares of the company's stock, valued at $217,466.40. Learn More on Jack W. Lasersohn's trading history.

Who are Silk Road Medical's active insiders?

Silk Road Medical's insider roster includes Lucas Buchanan (CFO), Andrew Davis (Insider), Jack Lasersohn (Director), Erica Rogers (CEO), and Richard Ruedy (EVP). Learn More on Silk Road Medical's active insiders.

Are insiders buying or selling shares of Silk Road Medical?

In the last twelve months, Silk Road Medical insiders bought shares 1 times. They purchased a total of 11,700 shares worth more than $198,783.00. In the last twelve months, insiders at the sold shares 6 times. They sold a total of 22,791 shares worth more than $414,491.49. The most recent insider tranaction occured on August, 19th when EVP Kevin M Klemz sold 2,268 shares worth more than $61,462.80. Insiders at Silk Road Medical own 3.9% of the company. Learn More about insider trades at Silk Road Medical.

Information on this page was last updated on 8/19/2024.

Jack W. Lasersohn Insider Trading History at Silk Road Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2021Sell5,427$45.60$247,471.204,769View SEC Filing Icon  
See Full Table

Jack W. Lasersohn Buying and Selling Activity at Silk Road Medical

This chart shows Jack W Lasersohn's buying and selling at Silk Road Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Silk Road Medical Company Overview

Silk Road Medical logo
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $27.49
Low: $27.49
High: $27.49

50 Day Range

MA: $27.31
Low: $27.01
High: $27.50

2 Week Range

Now: $27.49
Low: $6.08
High: $27.51

Volume

N/A

Average Volume

1,200,763 shs

Market Capitalization

$1.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53